Navigation Links
NimbleGen to be part of new cancer study

ctivities of a class of proteins called transcription factors," said Bing Ren, head of the Laboratory of Gene Regulation at LICR. "These proteins are molecular switches that control the program of gene expression in the human genome. This project represents the most comprehensive analysis of the function of several transcription factors involved in breast and colon cancers, and the results should ......

Full article >>>
'"/>

Source:wistechnology.com By WTN News 10/12/05


Page: 1 2

Related biology technology :

1. NimbleGen researcher to lead $415K DNA project
2. NimbleGen to discontinue IPO after Roches $272.5 million acquisition
3. IPO-bound NimbleGen traveling in fast company
4. Madison biotech NimbleGen files for IPO; one of states best-funded firms
5. Genomics researcher Hood joins NimbleGen board
6. NimbleGen partners with UK biotech firm
7. NimbleGen extends research market reach
8. NimbleGen microarrays speed genetic findings
9. NimbleGen names CFO with capital-raising past
10. NimbleGen partners with leading researchers
11. NimbleGen closes $8.2m venture round, bringing total to $50m
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: NimbleGen part new cancer study

(Date:7/28/2015)... , July 28, 2015 Tauriga Sciences, ... diversified life sciences company, today announced that its stockholders ... of common stock of the Company from 1,000,000,000 to ... July 27, 2015 at the Law Offices of Nixon ... the Special Meeting, there were 480,655,929 shares of common ...
(Date:7/28/2015)... N.J. , July 28, 2015  Moerae ... second Phase 1 clinical trial with MMI-0100, a ... is being developed for pulmonary disorders characterized by ... United Kingdom , is a ... further evaluating the safety and tolerability of MMI-0100 ...
(Date:7/28/2015)... 2015 CSL Behring announced today ... for review the company,s Biologics License Application (BLA) for ... the treatment of hemophilia A. In the pivotal clinical ... Hemophilia A is a congenital bleeding disorder ... affected patients are male. People with hemophilia A may ...
(Date:7/28/2015)... SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., ... UTHR ) today announced its financial results for ... "Orenitram ®  sales grew nearly 300% as compared ... product was first launched," said Roger Jeffs, Ph.D., ... growth in Orenitram sales was due to an ...
Breaking Biology Technology:Tauriga Sciences, Inc. Stockholders Approve Increase In Authorized Common Stock 2Tauriga Sciences, Inc. Stockholders Approve Increase In Authorized Common Stock 3Moerae Initiates Lipopolysaccharide (LPS) Challenge Study of Inhaled MMI-0100 for Pulmonary Disease Following Encouraging Safety and Tolerability Observed in Single Ascending Dose Phase 1 Study 2U.S. FDA Accepts for Review CSL Behring's Biologics License Application for Its Novel rVIII-SingleChain Therapy for Patients with Hemophilia A 2U.S. FDA Accepts for Review CSL Behring's Biologics License Application for Its Novel rVIII-SingleChain Therapy for Patients with Hemophilia A 3United Therapeutics Corporation Reports Second Quarter 2015 Financial Results 2United Therapeutics Corporation Reports Second Quarter 2015 Financial Results 3United Therapeutics Corporation Reports Second Quarter 2015 Financial Results 4United Therapeutics Corporation Reports Second Quarter 2015 Financial Results 5United Therapeutics Corporation Reports Second Quarter 2015 Financial Results 6United Therapeutics Corporation Reports Second Quarter 2015 Financial Results 7United Therapeutics Corporation Reports Second Quarter 2015 Financial Results 8United Therapeutics Corporation Reports Second Quarter 2015 Financial Results 9United Therapeutics Corporation Reports Second Quarter 2015 Financial Results 10United Therapeutics Corporation Reports Second Quarter 2015 Financial Results 11
... March 25 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. ("Oncolytics") ... completion of patient enrolment in its U.K. clinical ... administration of REOLYSIN(R) in combination with gemcitabine (Gemzar(R)) ... head and neck. The principal investigators are Dr. ...
... plus Double Digit Royalties on Future Sales - - ... Today - EMERYVILLE, Calif., March 25 NovaBay Pharmaceuticals, ... biopharmaceutical company developing first-in-class anti-infective products for the treatment ... causing resistance, today announced that it has entered into ...
... Therapeutics, Inc. (CTI) (NASDAQ and MTA: CTIC) announced today ... on Tuesday, March 24, 2009.At the meeting, shareholders approved ... authorized stock (including an increase in the number of ... the number of shares available for issuance under its ...
Cached Biology Technology:Oncolytics Biotech(R) Inc. Completes Enrolment in Combination REOLYSIN(R)/Gemcitabine Trial 2Oncolytics Biotech(R) Inc. Completes Enrolment in Combination REOLYSIN(R)/Gemcitabine Trial 3NovaBay and Galderma Enter Into Global Agreement to Develop and Commercialize NovaBay's Novel Aganocide Drugs for Major Dermatological Conditions 2NovaBay and Galderma Enter Into Global Agreement to Develop and Commercialize NovaBay's Novel Aganocide Drugs for Major Dermatological Conditions 3NovaBay and Galderma Enter Into Global Agreement to Develop and Commercialize NovaBay's Novel Aganocide Drugs for Major Dermatological Conditions 4NovaBay and Galderma Enter Into Global Agreement to Develop and Commercialize NovaBay's Novel Aganocide Drugs for Major Dermatological Conditions 5NovaBay and Galderma Enter Into Global Agreement to Develop and Commercialize NovaBay's Novel Aganocide Drugs for Major Dermatological Conditions 6Cell Therapeutics, Inc. Reports Outcome of Special Meeting of Shareholders 2
(Date:6/30/2015)... , June 30, 2015 Genisphere ... as CEO to help further develop Genisphere,s therapeutics capabilities ... partnering experience, having spent much of the last 25 ... Amgen, Baxter Bioscience, and Johnson & Johnson. Tom started ... Technology and Biotech Corporate Finance. He graduated from Dartmouth ...
(Date:6/25/2015)... , June 25, 2015  Imagine a tool specifically ... a healthier, happier life. That,s exactly what USANA,s ... do. The cutting-edge, portable health program provides a personalized ... to help improve your lifestyle and nutrition. ... and gala Wednesday night, USANA,s THA was honored with ...
(Date:6/24/2015)... , June 24, 2015  Synaptics Inc. ... human interface solutions, today announced that Sharp has ... provide secure authentication for its latest flagship smartphone ... more than 200 million shipments of its fingerprint ... reinforces Synaptics, strength, scalability and leadership in the ...
Breaking Biology News(10 mins):Genisphere Appoints New CEO, Thomas Bliss 2Genisphere Appoints New CEO, Thomas Bliss 3@USANAinc's Personalized Nutrition Program Wins Industry Innovation Award 2Synaptics Brings Natural ID Technology to Sharp's Newest Flagship Smartphone 2
... Delaware, in collaboration with Stroud Water Research Center in ... the National Science Foundation to establish the Christina River ... questions relating to climate change. Scientists define the ... the treetops to the groundwater that sustains terrestrial life. ...
... costs outweigh benefits, successful pregnancies are less likely to ... recently published research by Virginia J. Vitzthum, a senior ... Sex, Gender, and Reproduction, and professor in the IU ... shown that during periods of intense labor and low ...
... newest of five international sites where volunteers work with ... effects of climate change on forests, opened Sept. 22 ... "It is extremely rewarding to collaborate with scientists in ... to comprehend the effects of climate change on forest ...
Cached Biology News:Critical Zone Observatory seeks to answer climate change questions 2Critical Zone Observatory seeks to answer climate change questions 3Critical Zone Observatory seeks to answer climate change questions 4Studies examine how living conditions impact reproductive health 2China's new Climate Center welcomes citizen scientists 2